Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Proscar
Generic name / active ingredient
finasteride
Dosage-form class
Oral film-coated tablet: 5 mg per tablet; this dossier precisely displays the NDC 78206-153-01 30-tablet bottle; PROPECIA 1 mg is not included
Route
Oral
Record reviewed
2026-08-21

Copy from the pack in hand

Source-linked reading points

  • Check PROSCAR, finasteride, 5 mg per tablet, NDC 78206-153-01, oral film-coated tablet, actual pack and target market together. Although PROPECIA also contains finasteride, its U.S. label is for a distinct 1 mg product for male-pattern hair loss; a shared ingredient or milligram number does not establish self-directed substitution, combination or proportional conversion.
  • The label identifies PROSCAR for symptomatic BPH in men with an enlarged prostate. Shared urinary or prostate wording does not establish that it can be self-combined, substituted or alternated with tamsulosin, dutasteride, herbs or another urological product.
  • The U.S. label states that women who are or may be pregnant should not use PROSCAR or handle crushed or broken tablets. This warning is safety information for this exact product; do not change handling of intact tablets because of appearance, a similar name or an assertion that a tablet can be split.
  • When using several urological, cardiovascular, hormonal, OTC or supplement products, or preparing for a prostate-related evaluation, bring the actual packs and complete medicine list to a pharmacist or clinician. A webpage cannot turn label wording into an individual diagnosis, screening interpretation or medicine plan.

Reviewed presentation examples — compare every field

  • 5 mg per tablet; 30-tablet bottleNDC 78206-153-01

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-21
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image